1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Clinical data in patients with late-onset OTCD
Patient No./Age (y)/Sex OTC Mutation Clinical Manifestations Therapy Outcome Day of MR Imaging NH3 Level at MR Imaging Maximum NH3 Level 1/2.5/M Arg40His Obtunded, vomiting, ataxia Medication Improved, hospitalized 10 d Day 7 165 235 2/7/F Deletion involving exons 9 and 10 Lethargy, ataxia, seizure Medication Improved, hospitalized 7 d Day 2 195 293 3/62/M Pro225Thr Vomiting, coma, seizure Medication, hemodialysis Died after 5 d Day 10 183 2050